MTOR and myeloid leukemia: In line with this, synergy between inhibition of members of the anti-apoptotic Bcl-2 family and inhibition of PI3K/AKT/mTor signaling has recently been reported for human myeloid leukemia and diffuse large B-cell lymphoma cells [48, 49].